Complexity of expression of antigenic determinants, recognized by monoclonal antibodies HMFG-1 and HMFG-2, in normal and malignant human mammary epithelial cells

The monoclonal antibodies HMFG-1 and HMFG-2 super(1) are produced by hybridomas derived by fusing spleen cells of mice immunized with delipidated preparations of the human milk fat globule. Enzyme-linked immunosorbent (ELISA) assays of Western blots prepared from gels separating components of the mi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of immunology (1950) 1983-07, Vol.131 (1), p.508-513
Hauptverfasser: Burchell, J, Durbin, H, Taylor-Papadimitriou, J
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The monoclonal antibodies HMFG-1 and HMFG-2 super(1) are produced by hybridomas derived by fusing spleen cells of mice immunized with delipidated preparations of the human milk fat globule. Enzyme-linked immunosorbent (ELISA) assays of Western blots prepared from gels separating components of the milk fat globule showed that both antibodies recognize determinants found in high molecular weight components (> 400 K). Lectin-blocking experiments indicated that both antibodies recognize oligosaccharide sequences containing galactose, N-acetyl glucosamine, and, possibly, N-acetyl galactosamine. However, the determinant recognized by HMFG-1 is different from the determinant recognized by HMFG-2, which may contain or be adjacent to a nonterminal sialic acid residue. The expression of these antigenic determinants by normal mammary epithelial cells cultured from milk (HumE) and by a breast cancer cell line (T47D), was studied. The results are consistent with the interpretation that the HMFG-1 determinant is present in large glycoprotein molecules with complex carbohydrate side chains, and the HMFG-2 determinant is more commonly found in smaller molecules where glycosylation may be incomplete and sialic acid residues more exposed. The preferential binding of HMFG-2 to some breast cancers may therefore reflect a changed glycosylation pattern in these cells.
ISSN:0022-1767
1550-6606
DOI:10.4049/jimmunol.131.1.508